Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Synflorix on Carriage, AOM, and Safety in Children
NCT00839254Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in invasive pneumococcal disease (IPD), pneumonia, acute otitis media (AOM), sponsored by GSK. Started Feb 2009; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
invasive pneumococcal disease (IPD)pneumoniaacute otitis media (AOM)
Beyond the preview
Go deeper on NCT00839254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839254.